The 2017 Access to Vaccines Index has mapped how vaccine companies are responding to global calls to improve immunisation coverage. The companies approach access to vaccines in differing ways, which are generally linked to their diverse pipelines, portfolios, revenues and sales.

The Index includes report cards for the eight companies evaluated. Each one includes an overview of the company’s portfolio and pipeline, and identifies tailored opportunities for it to increase access to vaccines.